High Prevalence of BTK Mutations on Ibrutinib Therapy after 3 Years of Treatment in a Real-Life Cohort of CLL Patients: A Study from the French Innovative Leukemia Organization (FILO) Group

著录项

• 来源
  《Blood: The Journal of the American Society of Hematology》 |2018年第novaelatreatmentappr期|共3页
• 作者

  Quinquenel Anne; Fornecker Luc Matthieu; Letestu Remi; Fleury Carole; Ysebaert Loic; Dilhuydy Marie-Sarah; Guieze Romain; Feugier Pierre; Roos-Weil Damien; Willems Lise; Michallet Anne-Sophie; Delmer Alain Jacques; Taverna Pietro; Fox Judith A.; Levy Vincent; Cymbalista Florence; Baran-Marszak Fanny;

  展开▼
• 作者单位

  CHU Reims Hop Robert Debre Reims France;

  CHU Strasbourg Hematol Dept Strasbourg France;

  Hop Avicenne AP HP Lab Hematol Bobigny France;

  Hop Avicenne Lab Hematol Bobigny France;

  IUCT Oncopole Hematol Dept Toulouse France;

  CHU Hop Bordeaux Pessac France;

  Univ Hosp Clermont Ferrand Clin Hematol Unit Adult Cell Therapy &

  Clin Hematol Clermont Ferrand;

  CHU Nancy Hematol Dept Vandoeuvre Les Nancy France;

  UPMC Univ Paris 06 Sorbonne Univ Hop Pitie Salpetriere Hematol Dept GRC 11 Paris France;

  Cochin Hosp Hematol Dept Paris France;

  Ctr Leon Berard Serv Hematol Lyon France;

  CHU Reims Hop Robert Debre Reims France;

  Sunesis Pharmaceut San Francisco CA USA;

  Sunesis Pharmaceut San Francisco CA USA;

  Hop Avicenne Bobigny France;

  Hop Avicenne Lab Hematol Bobigny France;

  Hop Avicenne Lab Hematol Bobigny France;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 血液及淋巴系疾病;
• 关键词